"In support of the clinical mission, there is a robust basic science and clinical research enterprise focusing on changing the course of diseases such as amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, stroke and Parkinson's disease."
Boston Marathon a fitting tribute for families touched by ALS
Sisters Ashley Craig and Lacey Foley joined the UMass ALS Cellucci Fund Boston Marathon team in memory of their grandmother. Brothers Dean and Zack Kennedy, PhD’19, are running on the Jake Kennedy ALS Fund team, in honor of their father.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Office of Advancement, Alumni, Employee, Faculty, Research, Neurology, RNA Therapeutics Institute, Latest News, BRIDGE, Top Stories,
Research News
How frontotemporal dementia changes the brain
In a piece written for The Conversation, Fen-Biao Gao, PhD, talks about how frontotemporal dementia changes the brain and the research that is untangling its genetic causes.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Research, Rare Disease, Conversation, Fen-Biao Gao Lab, Neurology, Li Weibo Institute for Rare Diseases Research, Latest News,
Researchers working with UMass Chan Medical School’s Translational Institute for Molecular Therapeutics announced progress in developing a vector to deliver gene replacement therapy in mice models with Cockayne syndrome, a rare and fatal neurodegenerative disease that largely affects children and young adults.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Research, Rare Disease, Rare Diseases, Miguel Sena-Esteves, Neurology, Latest News,
